The Vial Big Pharma Fears
30:09–32:29 · 140s
He claims compounded tirzepatide vials threaten pharmas business model by enabling flexible microdosing, prompting an unprecedented FDA crackdown influenced by corporate pressure.
30:09–32:29 · 140s
He claims compounded tirzepatide vials threaten pharmas business model by enabling flexible microdosing, prompting an unprecedented FDA crackdown influenced by corporate pressure.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.